Cargando…
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
BACKGROUND: Hydroxychloroquine or chloroquine with or without azithromycin have been widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro antiviral effects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). OBJECTIVE: The aim of this systematic rev...
Autores principales: | Fiolet, Thibault, Guihur, Anthony, Rebeaud, Mathieu Edouard, Mulot, Matthieu, Peiffer-Smadja, Nathan, Mahamat-Saleh, Yahya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449662/ https://www.ncbi.nlm.nih.gov/pubmed/32860962 http://dx.doi.org/10.1016/j.cmi.2020.08.022 |
Ejemplares similares
-
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response
por: Fiolet, Thibault, et al.
Publicado: (2021) -
Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response
por: Fiolet, Thibault, et al.
Publicado: (2021) -
Hydroxychloroquine and COVID-19: a tale of populism and obscurantism
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021) -
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
por: Mahamat-Saleh, Yahya, et al.
Publicado: (2021) -
An Umbrella Review of Clinical Efficacy and Adverse Cardiac Events Associated with Hydroxychloroquine or Chloroquine with or Without Azithromycin in Patients with COVID-19
por: Shahsavarinia, Kavous, et al.
Publicado: (2021)